Company Filing History:
Years Active: 2022
Title: Stefanie Breitenstein: Innovator in Neuromuscular Disease Treatment
Introduction
Stefanie Breitenstein is a prominent inventor based in Düsseldorf, Germany. She has made significant contributions to the field of pharmacology, particularly in the treatment of muscular and neuromuscular diseases. Her innovative work has the potential to improve the lives of many individuals suffering from these conditions.
Latest Patents
Stefanie holds a patent for the "Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases." This invention focuses on the pharmacology of mineralocorticoid receptor antagonists (MRAs) and their application in developing medicaments for the prevention and treatment of muscular diseases, especially Duchenne Muscular Dystrophy (DMD). She has 1 patent to her name.
Career Highlights
Stefanie is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. Her work at Bayer has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Stefanie has worked alongside notable colleagues such as Peter Sandner and Peter Kolkhof. Their combined expertise has fostered an environment of innovation and advancement in the treatment of neuromuscular diseases.
Conclusion
Stefanie Breitenstein's contributions to the field of pharmacology and her innovative patent for treating muscular diseases highlight her role as a key inventor in this vital area of healthcare. Her work continues to pave the way for new therapeutic options for patients in need.